TY - JOUR
T1 - Exploring the Association Between Serotonin 1 Transporter Promoter Region Methylation Levels and 2 Depressive Symptoms: A Systematic Review and Multi-level Meta-Analysis
AU - Javelle, Florian
AU - Gao, D
AU - Ringleb, Miriam
AU - Pulverer, Walter
AU - Bloch, W
N1 - © 2025. The Author(s).
PY - 2025/5/3
Y1 - 2025/5/3
N2 - Depressive disorders result from complex interactions among genetic, epigenetic, and environmental factors. DNA methylation, a key epigenetic mechanism, is crucial in understanding depressive symptoms development. The serotonin transporter gene (5-HTT) and its polymorphisms, like 5-HTTLPR, have been extensively studied in relation to depression, yet conflicting findings regarding the association between 5-HTT promoter methylation and depressive symptoms persist, largely due to methodological differences. Thus, this systematic review and meta-analysis aims to assess (1) 5-HTT promoter methylation levels between depressed and non-depressed conditions and (2) the association between 5-HTT methylation and depressive symptoms severity. We searched PubMed, Google Scholar, and Web of Science from inception to January 15th, 2025 (PROSPERO: CRD42023355414) and performed two independent multi-level meta-analyses to answer our aims. Twenty-four trials were included in the systematic review. All reported effects carried potential for bias. The meta-analysis for depression occurrence (12 studies - 2028 subjects – 127 effects) indicated no significant effect (Hedges’g = 0.06) with moderate within- and low between-study heterogeneity. The depression severity analysis (14 studies - 2296 subjects - 116 effects) revealed a null effect size (Fisher’s Z = 0.05), with no within- and moderate between-study heterogeneity. Asymmetry was detected for both meta-analyses. Moderator analyses demonstrated no significant effects of depression severity, methylation techniques, single-CpG sites, cell types assessed, age, and female percentage. This comprehensive review provides insights into the intricate interplay between 5-HTT promoter methylation and depressive symptoms. Furthermore, it offers well-considered recommendations for future research endeavors and delineates guidelines for reporting methylation research.
AB - Depressive disorders result from complex interactions among genetic, epigenetic, and environmental factors. DNA methylation, a key epigenetic mechanism, is crucial in understanding depressive symptoms development. The serotonin transporter gene (5-HTT) and its polymorphisms, like 5-HTTLPR, have been extensively studied in relation to depression, yet conflicting findings regarding the association between 5-HTT promoter methylation and depressive symptoms persist, largely due to methodological differences. Thus, this systematic review and meta-analysis aims to assess (1) 5-HTT promoter methylation levels between depressed and non-depressed conditions and (2) the association between 5-HTT methylation and depressive symptoms severity. We searched PubMed, Google Scholar, and Web of Science from inception to January 15th, 2025 (PROSPERO: CRD42023355414) and performed two independent multi-level meta-analyses to answer our aims. Twenty-four trials were included in the systematic review. All reported effects carried potential for bias. The meta-analysis for depression occurrence (12 studies - 2028 subjects – 127 effects) indicated no significant effect (Hedges’g = 0.06) with moderate within- and low between-study heterogeneity. The depression severity analysis (14 studies - 2296 subjects - 116 effects) revealed a null effect size (Fisher’s Z = 0.05), with no within- and moderate between-study heterogeneity. Asymmetry was detected for both meta-analyses. Moderator analyses demonstrated no significant effects of depression severity, methylation techniques, single-CpG sites, cell types assessed, age, and female percentage. This comprehensive review provides insights into the intricate interplay between 5-HTT promoter methylation and depressive symptoms. Furthermore, it offers well-considered recommendations for future research endeavors and delineates guidelines for reporting methylation research.
KW - DNA Methylation
KW - serotonin transporter
KW - depressive symptoms
KW - Serotonin Plasma Membrane Transport Proteins/genetics
KW - Humans
KW - DNA Methylation
KW - Promoter Regions, Genetic
KW - Depression/genetics
KW - Epigenesis, Genetic
UR - https://www.nature.com/articles/s41398-025-03356-w?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20250504&utm_content=10.1038/s41398-025-03356-w
U2 - 10.1038/s41398-025-03356-w
DO - 10.1038/s41398-025-03356-w
M3 - Article
C2 - 40319044
SN - 2158-3188
VL - 15
JO - Translational Psychiatry
JF - Translational Psychiatry
IS - 1
ER -